EX-FILING FEES 2 ibrx-20240620xs8exhibit107.htm EX-FILING FEES Document
Exhibit 107
Calculation of Filing Fee Table
Form S-8
(Form Type)
ImmunityBio, Inc.
(Exact Name of Registrant as Specified in its Charter)
Newly Registered Securities
Security
Type
Security
Class
Title
Fee
Calculation
Rule
Amount
Registered (1)
Proposed
Maximum
Offering
Price
Per
Share (3)
Maximum
Aggregate
Offering
Price
Fee
Rate
Amount of
Registration
Fee
Equity
Common
Stock, par
value
$0.0001
per share
Rule 457(c)
and
Rule 457(h)
19,900,000 (2)
$5.7225
$113,877,750
$147.60 per
$1,000,000
$16,808.36
Total Offering Amount$113,877,750$16,808.36
Total Fee Offsets
Net Fee Due$16,808.36
_______________
(1)Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the common stock, par value $0.0001 per share, (“Common Stock”) of ImmunityBio, Inc. (the “Registrant”) that became issuable under the Registrant’s 2015 Equity Incentive Plan, as amended (the “Plan”) by reason of an event such as any stock split, stock dividend, recapitalization or similar transaction effected without receipt of consideration that increases the number of the Registrant’s outstanding shares of Common Stock.
(2)Represents 19,900,000 additional shares of Common Stock available for issuance pursuant to the Plan, as a result of an amendment to the Plan approved at the Registrant’s 2024 annual meeting of stockholders.
(3)Estimated in accordance with Rule 457(h) under the Act solely for the purpose of calculating the registration fee based on the average of the high and low prices of Common Stock on the Nasdaq on June 13, 2024, in accordance with Rule 457(c) under the Act.